A jury in Las Vegas, Nevada has been hearing arguments over safety issues associated with Takeda Pharmaceuticals’ type 2 diabetes medication, Actos.
The trial began on August 27, 2015 and is being heard before Judge Jerry Wiese in the Supreme Court of the State of Nevada, a consolidated case on behalf of a living plaintiff and the widow of a deceased man. Both men had been taking Actos (pioglitazone) and developed bladder cancer, which they allege was caused by the drug. Counsel for the plaintiffs will likely seek $2 billion in damages for the living man and for the widow. More Actos Bladder Cancer Trial Underway in Nevada